Advertisement
Advertisement
U.S. markets open in 1 hour 19 minutes
Advertisement
Advertisement
Advertisement
Advertisement

NanoVibronix Inc. (US63008J1088.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
0.3565-0.0046 (-1.27%)
As of 08:07AM CET. Market open.
Advertisement
Full screen
Loading interactive chart...
  • Simply Wall St.

    NanoVibronix Third Quarter 2022 Earnings: US$0.034 loss per share (vs US$0.26 loss in 3Q 2021)

    NanoVibronix ( NASDAQ:NAOV ) Third Quarter 2022 Results Key Financial Results Revenue: US$97.0k (down 81% from 3Q...

  • Benzinga

    Interim Results Of NanoVibronix's Uroshield Show Beneficial Effects For Patients

    NanoVibronix Inc (NASDAQ: NAOV) announced interim results of its U.K. clinical study for UroShield, a disposable ultrasound device that reduces biofilm contaminating the catheter surface. Initial results of the independent, real-world patient study suggest changes in the microbial population diversity following the use of the Uroshield, with potential beneficial effects on the urinary and catheter microbiome. Indwelling urinary catheters are commonly used devices to resolve urinary retention pro

  • Benzinga

    Health Canada Approves NanoVibronix's PainGuard, UroGuard As Licensed Devices

    NanoVibronix Inc's (NASDAQ: NAOV) PainGuard and UroGuard have been approved by Health Canada / Santé Canada as licensed medical devices. The products are offered as private label products through Ideal Medical International Limited. "This license clears the way for our distribution partner, Ideal Medical, to accelerate the distribution of our products in Canada, another catalyst for our potential future growth and international expansion," said Brian Murphy, CEO of NanoVibronix. "According to th

Advertisement
Advertisement